TrialJournal of translational medicine2014

A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).

Shoichi Hazama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.